Ms Nele Henrike Thomas

Institute for Biostatistics, Hannover (Germany)

Membership: ESC Professional Member

Follow

Contributor content

Why to avoid dual primary endpoints in cardiovascular trials

Presentation

Why to avoid dual primary endpoints in cardiovascular trials

ESC 365 is supported by

novartis

Explore sponsored resources